WHO Drug Information - Volume 36, No. 2

Overview

The second issue of Volume 36, includes

Consultation Documents:

  • Linezolid (linezolidum)
  • Linezolid tablets (linezolidi compressi)
  • Isoniazid (isoniazidum)
  • Isoniazid tablets (isoniazidi compressi)

ATC/DDD Classification

  • ATC/DDD Classification (Temporary)
  • ATC/DDD Classification (Final)

International Nonproprietary Names List:

Issue 2 concludes with List No. 127 of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances.

This proposed list contains:

  • INN list 127 - from page 305 to 552 (deadline for objecting and commenting is 21 November 2022)
  • INN list 127 – COVID-19 (special edition) page(s) 553 - 554 (This part has already been published on the INN website - explanatory note on page 554 of this volume. Deadline for objecting and commenting was 24 May 2022)
  • INN list 127 – COVID-19 (special edition) ADDENDUM page(s) 555 to 567 (deadline for objecting and commenting is 21 November 2022)

 

WHO Team
Access to Medicines and Health Products (MHP), INN and Classification of Medical Products (INN), Prequalification (PQT), Regulation and Prequalification (RPQ), Regulation and safety (REG)
Editors
World Health Organization
Number of pages
336
Reference numbers
ISBN: 9789240053199
Copyright